⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CTXR News
Citius Pharmaceuticals Inc. Common
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
prnewswire.com
CTOR
CTXR
CTOR
CTXR
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
prnewswire.com
CTOR
CTXR
CTOR
CTXR
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
prnewswire.com
CTOR
CTXR
CTOR
CTXR
Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead of LYMPHIR Launch
prnewswire.com
CTOR
CTXR
CTOR
CTXR